Negatively charged nanodiscs for the reduction of toxicity and enhanced efficacy of polymyxin B against Acinetobacter baumannii sepsis
Acta Biomaterialia · 2024-08 · 184 · 323-334
DOI: 10.1016/j.actbio.2024.06.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2024-08. Verfasst von Penghe Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical Coll…. Hauptthemen laut MEDLINE: Polymyxin B, Acinetobacter baumannii, Acinetobacter Infections, Sepsis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Science and Technology Infrastructure Program, CAMS Innovation Fund for Medical Sciences, Fundamental Research Funds for the Central Universities.
Themen: Sepsis
Abstract (Originalsprache)
The treatment of sepsis caused by multidrug-resistant (MDR) Gram-negative bacterial infections remains challenging. With these pathogens exhibiting resistance to carbapenems and new generation cephalosporins, the traditional antibiotic polymyxin B (PMB) has reemerged as a critical treatment option. However, its severe neurotoxicity and nephrotoxicity greatly limit the clinical application. Therefore, we designed negatively charged high-density lipoprotein (HDL) mimicking nanodiscs as a PMB delivery system, which can simultaneously reduce toxicity and enhance drug efficacy. The negative charge prevented the PMB release in physiological conditions and binding to cell membranes, significantly reducing toxicity in mammalian cells and mice. Notably, nanodisc-PMB exhibits superior efficacy than free PMB in sepsis induced by carbapenem-resistant Acinetobacter baumannii (CRAB) strains. Nanodisc-PMB shows promise as a treatment for carbapenem-resistant Gram-negative bacterial sepsis, especially caused by Acinetobacter baumannii, and the nanodiscs could be repurposed for other toxic antibiotics as an innovative delivery system. STATEMENT OF SIGNIFICANCE: Multidrug-resistant Gram-negative bacteria, notably carbapenem-resistant Acinetobacter baumannii, currently pose a substantial challenge due to the scarcity of effective treatments, rendering Polymyxins a last-resort antibiotic option. However, their therapeutic application is significantly limited by severe neurotoxic and nephrotoxic side effects. Prevailing polymyxin delivery systems focus on either reducing toxicity or enhancing bioavailability yet fail to simultaneously achieve both. In this scenario, we have developed a distinctive HDL-mimicking nanodisc for polymyxin B, which not only significantly reduces toxicity but also improves efficacy against Gram-negative bacteria, especially in sepsis caused by CRAB. This research offers an innovative drug delivery system for polymyxin B. Such advancement could notably improve the therapeutic landscape and make a significant contribution to the arsenal against these notorious pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China; Division for Medicinal Microorganisms Rela…
Förderung
- National Science and Technology Infrastructure Program
- CAMS Innovation Fund for Medical Sciences
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Wang, P., Xie, C., Zhang, Y., Li, H., Lu, Y., Sun, L., Hu, X., Nie, T., Li, C., Li, G., Lu, X., Pang, J., Yang, X., Yu, L., Li, X., Wang, X., & You, X. (2024). Negatively charged nanodiscs for the reduction of toxicity and enhanced efficacy of polymyxin B against Acinetobacter baumannii sepsis. Acta Biomaterialia, 184, 323-334. https://doi.org/10.1016/j.actbio.2024.06.017
Vancouver
Wang P, Xie C, Zhang Y, Li H, Lu Y, Sun L, et al. Negatively charged nanodiscs for the reduction of toxicity and enhanced efficacy of polymyxin B against Acinetobacter baumannii sepsis. Acta Biomaterialia. 2024;184:323-334. doi:10.1016/j.actbio.2024.06.017
BibTeX
@article{Wang2024,
author = {Wang, Penghe and Xie, Chunyang and Zhang, Youwen and Li, Haibin and Lu, Yun and Sun, Lang and Hu, Xinxin and Nie, Tongying and Li, Congran and Li, Guoqing and Lu, Xi and Pang, Jing and Yang, Xinyi and Yu, Liyan and Li, Xue and Wang, Xiukun and You, Xuefu},
title = {Negatively charged nanodiscs for the reduction of toxicity and enhanced efficacy of polymyxin B against Acinetobacter baumannii sepsis},
journal = {Acta Biomaterialia},
year = {2024},
volume = {184},
pages = {323--334},
doi = {10.1016/j.actbio.2024.06.017}
}
EUVIMED